Peptides for weight loss: what they really are

What these compounds are

The family associated with metabolism and body composition are mostly incretin agonists: synthetic peptides acting on receptors of the incretin-glucagon system. That system regulates satiety signals and glucose metabolism, which is why the research literature studies them in energy metabolism models. incretin agonists: synthetic peptides acting on the receptors of the incretin-glucagon system. That system regulates satiety signaling and glucose metabolism, which is why the research literature studies them in energy metabolism models.

They differ from one another in how many receptors they activate. Semaglutide acts on one (GLP-1). Tirzepatide on two (GIP and GLP-1). Retatrutide on three (GIP, GLP-1 and glucagon). There are also compounds reaching the same ground by other routes, such as MOTS-c, a mitochondrial peptide, or 5-Amino-1MQ, which inhibits the NNMT enzyme.

The difference almost nobody explains: approved medicine or reagent

It is the most important distinction on this page. Some of these molecules do exist as an approved medicine: semaglutide and tirzepatide hold marketing authorizations in several countries, are sold under brand names, require a prescription and are backed by clinical trials with their own prescribing information. do exist as an approved medicine: semaglutide and tirzepatide hold marketing authorization in several countries, are sold under brand names, require a medical prescription and are backed by clinical trials with a summary of product characteristics.

What amino distributes is not that. It is the same molecule synthesized as reference material for the laboratory, defined by its certificate of analysis — identity and purity verified by HPLC — and not by a marketing authorization. No prescription, no medicine labeling, and no substitute for one. no es eso. It is the same molecule synthesized as reference material for the laboratory, defined by its certificate of analysis — identity and purity verified by HPLC — and not by a marketing authorization. It carries no prescription, no medicine label and does not replace one.

The practical consequence: the clinical evidence that exists belongs to the approved medicine and its supervised context of use. Carrying it over to a research vial would be dishonest, and it is exactly what many sites in this sector do. Retatrutide, for instance, does not even hold that approval anywhere: it remains in clinical investigation.

The compounds of this family in the catalog

Each with its own page, its batch certificate and its price range as a research reagent.

What the literature documents specifically in women

It deserves its own section for a solid reason: the clinical programs for this family were run in largely female populations — around two out of every three participants in the obesity trials — and yet the detail that affects a woman most is precisely the one that almost never appears translated into Spanish.

Oral contraceptives. The label of approved tirzepatide warns that it may reduce the effectiveness of oral contraceptives. The mechanism is delayed gastric emptying, which alters absorption of the pill; the manufacturer's recommendation is to use a barrier method or a non-oral contraceptive during the first four weeks and after each dose increase. It is a documented interaction, not a hypothesis, and it is the first thing worth knowing.

Pregnancy and breastfeeding. Agonists in this family are contraindicated in pregnancy, and pregnancy follow-up registries are open precisely because data in that population are limited. Breastfeeding is treated with the same caution.

Polycystic ovary syndrome. This is an active line of research: the relationship between insulin resistance and PCOS means the incretin axis is studied in that context. A line of research means exactly that — there are studies under way, not an established indication.

All of the above belongs to the label of the approved medicine and to the clinical literature behind it. It is collected here because it is safety information that circulates little in Spanish, not because it describes the use of a laboratory reagent, which has no use in people. Any decision about an approved medicine rests with the person prescribing it.

What to check if you are buying research material

Whatever the supplier, three things are verifiable and worth demanding: that the vial arrives sealed, that it has an identified batch number, and that the batch has a verifiable certificate of analysis with purity measured by HPLC. A compound without a certificate is not cheap — it is undetermined, because there is no way to know what it contains or in what proportion. sellado, that it carries an identified batch number, and that the batch has a verifiable certificate of analysis with purity measured by HPLC. A compound without a certificate is not cheap: it is undetermined, because there is no way to know what it contains or in what proportion.

At amino every batch publishes its certificate and it can be checked before buying on the batch verification page. There is also a reconstitution calculator for handling the lyophilized vial in the laboratory.

The two most-searched molecules of the family are compared in detail in retatrutide vs tirzepatide.

FAQ

amino makes no claims of efficacy or safety in humans. The information on this page summarizes research literature for technical reference and does not constitute medical advice, an indication of use, or a dosing suggestion. All compounds are research-grade reagents (RUO) for laboratory use only.